Status:
WITHDRAWN
Providing Access to Cord Blood Units for Transplants
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Chronic Myelogous Leukemia/Other Leukemia
Acute Leukemias
Eligibility:
All Genders
Up to 99 years
Phase:
PHASE2
Brief Summary
Background: \- Cord blood banks have been set up to collect and store umbilical cord blood for transplants. These transplants are used to treat different types of cancer. In October 2011, the Food an...
Detailed Description
Study Design: This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indication...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Patients with FDA-specified indications:
- Hematological malignancies
- Certain lysosomal storage and peroxisomal enzyme deficiency disorders
- Hurler syndrome (MPS I)
- Krabbe Disease (Globoid Leukodystrophy)
- X-linked Adrenoleukodystrophy
- Primary immunodeficiency diseases
- Bone marrow failure
- Beta-thalassemia
- Signed informed consent (and signed assent, if applicable)
- Pediatric and adult patients of any age
- EXCLUSION CRITERIA:
- Patients who are receiving only licensed CBUs
- Cord blood transplant recipients at international transplant centers
Exclusion
Key Trial Info
Start Date :
October 27 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 26 2012
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01479582
Start Date
October 27 2011
End Date
November 26 2012
Last Update
December 21 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.